ONUS Robotic Hospitals, through its esteemed ONUS Heart Institute, offers a comprehensive Transcatheter Aortic Valve Implantation (TAVI) program. This cutting-edge treatment is primarily indicated for patients with severe aortic stenosis (AS) who are considered high-risk or inoperable for traditional surgical aortic valve replacement (SAVR).
Transcatheter Aortic Valve Implantation (TAVI) is primarily indicated for patients with severe aortic stenosis (AS) who are considered high-risk or inoperable for traditional surgical aortic valve replacement (SAVR). However, with advancements in technology and experience, TAVI is increasingly being used in intermediate- and low-risk patients as well. The decision to perform TAVI is based on both clinical indications and risk stratification to ensure the best outcomes for the patient.
TAVI is specifically designed to address severe aortic stenosis, especially in patients who are considered high-risk for open-heart surgery due to factors such as:
By opting for TAVI, patients can benefit from a procedure that offers quicker recovery times, reduced pain, and fewer complications compared to conventional surgical methods.
ONUS Heart Institute’s vision is to revolutionize heart valve care by making minimally invasive, life-saving treatments like TAVI accessible and affordable for every patient.
– Deliver excellence in cardiovascular care
– Empower patients and communities
– Promote innovation and education
– Drive healthcare equity